Department of Geriatric Psychiatry, Institute of Mental Health, Singapore; Saw Swee Hock School of Public Health, National University of Singapore, Singapore.
J Am Med Dir Assoc. 2019 Aug;20(8):1054.e1-1054.e9. doi: 10.1016/j.jamda.2019.02.012. Epub 2019 Mar 26.
Neuropsychiatric symptoms (NPS) have been recognized to increase the risk of dementia among individuals with mild cognitive impairment (MCI). However, it is unclear whether the risk is shared across the various NPS or driven primarily by selected few symptoms. This study sought to provide confirmatory evidence on the comparative risk of dementia across the various NPS in MCI.
Cohort study (median follow-up 4.0 years; interquartile range 2.1-6.4 years).
Alzheimer's Disease Centers across the United States.
Participants ≥60 years of age and diagnosed with MCI at baseline (n = 8530).
Participants completed the Neuropsychiatric Inventory-Questionnaire at baseline and were followed up almost annually for incident dementia. Symptom clusters of NPS, as identified from confirmatory factor analyses, were included in Cox regression to investigate their comparative risks of dementia.
Three symptom clusters of NPS were identified among participants with MCI, namely hyperactivity, affective, and psychotic symptoms. The risk of dementia was present among participants with affective symptoms [hazard ratio (HR) 1.6, 95% confidence interval (CI) 1.4-1.9] and psychotic symptoms (HR 1.6, 95% CI 1.2-2.2), but not among those with hyperactivity symptoms (HR 1.1, 95% CI 0.9-1.3). The risk was higher when affective symptoms and psychotic symptoms co-occurred (HR 2.5, 95% CI 2.0-3.2), with one-half of the participants in this group developing dementia within 2.7 years of follow-up.
The findings illustrate the potential usefulness of NPS as a convenient prognostic tool in the clinical management of MCI. They also suggest the need for future research to focus on affective/psychotic symptoms in MCI when studying the neurobiological links between NPS and neurodegenerative processes.
神经精神症状(NPS)已被认为会增加轻度认知障碍(MCI)个体患痴呆症的风险。然而,目前尚不清楚这种风险是否存在于各种 NPS 之间,还是主要由少数几种症状驱动。本研究旨在为 MCI 中各种 NPS 的痴呆风险提供确证性证据。
队列研究(中位随访时间 4.0 年;四分位间距 2.1-6.4 年)。
美国各地的阿尔茨海默病中心。
≥60 岁且基线时被诊断为 MCI 的参与者(n=8530)。
参与者在基线时完成了神经精神问卷,并在几乎每年进行一次随访,以确定是否发生痴呆。从验证性因素分析中确定的 NPS 症状群被纳入 Cox 回归,以研究它们对痴呆的相对风险。
在 MCI 参与者中确定了 3 个 NPS 症状群,即活动过度、情感和精神病性症状。情感症状(HR 1.6,95%置信区间 1.4-1.9)和精神病性症状(HR 1.6,95%置信区间 1.2-2.2)的参与者存在痴呆风险,但活动过度症状(HR 1.1,95%置信区间 0.9-1.3)的参与者不存在痴呆风险。当情感症状和精神病性症状同时出现时,风险更高(HR 2.5,95%置信区间 2.0-3.2),该组中有一半的参与者在随访 2.7 年内发展为痴呆。
研究结果表明,NPS 作为 MCI 临床管理中的一种便捷预后工具具有潜在的应用价值。它们还表明,未来的研究需要在研究 NPS 与神经退行性过程之间的神经生物学联系时,关注 MCI 中的情感/精神病性症状。